Health Care Services

ModivCare

ModivCare Inc. Restores Compliance with NASDAQ Listing Standards

ModivCare Holds Annual General Meeting and Elects Seven Directors

ModivCare Inc. Releases 2024 Sustainability Report

Law Firm Investigating Potential Misconduct at ModivCare

Boston Aristotle Capital Sells ModivCare Inc. Shares

Bragar Eagel & Squire Investigating ModivCare for Shareholders

Barrington Research Downgrades MODIVCARE INC Rating

ModivCare released FY2025 Q1 earnings on May 8 After-Market EST, actual revenue USD 650.65 M (forecast USD 644.87 M), actual EPS USD -3.52 (forecast USD -1.54)

ModivCare Inc Expected to Report EPS Loss of 50 Cents, Quarterly Revenue Down 5.6%

ModivCare Executives to Depart, Pushing for Organizational Flattening and Modernization

Bronstein, Gewirtz & Grossman Investigating ModivCare's Improper Conduct

ModivCare to Release FY2025 Q1 Earnings on May 8 After-Market EST, Forecast Revenue USD 644.87 M, EPS USD -1.54

ModivCare Inc Expected to Report a 50 Cent EPS Loss

ModivCare Inc. Submits Initial Beneficial Ownership Statement and Appoints New Director

Modivcare and Aetna Launch Self-service Health Stations

ModivCare Inc. Shareholders Urged to Contact Lawyers Regarding Securities Fraud Class Action

Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ModivCare, Inc.

Stephens & Co. Adjusts ModivCare Rating and Target Price

ModivCare released FY2024 Annual Earnings on March 6 After-Market (EST), actual revenue $2.788B (forecast $2.788B), actual EPS -$14.14 (forecast -$13.5833)

ModivCare released FY2024 Q4 earnings on March 6 After-Market (EST), actual revenue 702.8 M USD (forecast 703.3 M USD), actual EPS -1.6482 USD (forecast -1.19 USD)

AMC Robotics

Radiopharm Theranostics

Artiva Biotherapeutics

Netclass Tech

3 E Network Tech

Quipt Home Medical

Kaixin

Ascent Solar Tech

Click Holdings/BVI

Climb Bio

Cigna

BrightSpring Health Services - Unit

Labcorp

Quest Diagnostics

Hims & Hers Health

BrightSpring Health Services

Chemed

Option Care Health

GeneDx

CorVel

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap